Bifidobacterium animalis subsp lactis strain CECT 8145 and LTA thereof health uses
WO2025008468A1PCT designated stage expired Publication Date: 2025-01-09BIOPOLIS
Patent Information
- Application Number
- PCT/EP2024/068889
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-07-04
- Filing Date
- 2024-07-04
- Publication Date
- 2025-01-09
Smart Images
Figure IMGF000052_0001 
Figure IMGF000053_0001 
Figure IMGF000055_0001
Abstract
The invention relates to health uses of a composition comprising Bifidobacterium animalis subsp. lactis strain CECT 8145, in the form of viable and non-viable cells. and / or a lipoteichoic acid (LT A) thereof, more particularly, for its use in anxiety, pathogen protection, gut barrier or age-related conditions in a subject. Given the associated effects, the invention is thus useful for exploitation in pharmaceutical and veterinary areas, food and beverages developments, animal feed, or medical foods among others.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Uses of lipoteichoic acid from bifidobacteria
WO2021130219A1
Probiotic composition and application thereof in relieving depression and reducing fat accumulation
CN114028444A
Beverage before sleep and preparation method thereof
CN116098255A
Strain of Bifidobacterium animalis subsp. lactis CECT 8145 and use thereof for the treatment and / or prevention of excess weight and obesity and associated diseases
US10946051B2
Probiotic bacteria
US20150079040A1
Cited By
Probiotic composition for relieving sarcopenia obesity and application thereof
CN120173823A
Probiotic composition for alleviating sarcopenia obesity and application thereof
CN120173823B
Solid-format freeze-dried functional food with prebiotics and probiotics based on a green juice to improve metabolism and portability
WO2026155642A1